Healthcare AI Pulse: Google, Oura, Abu Dhabi, India, UK, China
Healthcare is where AI agents meet the most sensitive data and the clearest paperwork problem. This week five regions announced something. Here is what is live, what is only planned, and what is still unanswered.
Key takeaways
- Google Cloud launched Gemini for healthcare on 10 November, in preview, for tasks such as records synthesis and prior-authorisation review, with HCA Healthcare, Highmark Health and Northwell Health as launch partners [1][2].
- Oura signed a definitive agreement on 10 November to buy AI-native primary care company Counsel Health for $625 million in cash, expected to close before the end of the calendar year [4].
- Abu Dhabi's health department announced an AI Physician Assistant inside its Malaffi health records exchange, and India's National Health Authority selected EkaCare's ambient voice scribe for public facilities [5][6].
- In China, Reuters reports drugmakers are exploring marketing on doctor-facing AI apps after an anti-graft crackdown limited hospital visits [7].
- The UK accepted all 44 recommendations of its AI-in-healthcare commission in October, but the question of who is liable when medical AI fails is still open [8][9].
United States: agents move into the back office
Google Cloud's announcement describes Gemini for healthcare as bringing together information from electronic health records, billing platforms, clinical guidelines and Medicare datasets, then running multi-step workflows such as records synthesis and prior-authorisation review "within defined guardrails" and with human oversight [2]. For providers, Google says it assembles a patient's history across care settings, prepares charts before a visit and builds authorisation packets against payer policy; for health plans, it checks requests against medical policy [1]. It is built to support HIPAA compliance, according to Google, and is available in preview [1].
InterSystems said on 10 November it will be a launch partner, connecting Gemini to its IRIS FHIR server through the Model Context Protocol, the open standard that lets AI agents call tools [3]. The sources we read do not state pricing or regional availability, and we found no published performance results.
The same week brought the deal that shows the commercial direction. Oura, the smart-ring maker, agreed to pay $625 million in cash for Counsel Health, which pairs medical AI chat with on-demand physicians [4]. According to Oura, revenue for the quarter ended 30 September 2026 rose 153% to $533 million, and its fiscal 2026 revenue was about $1.75 billion; both figures are preliminary and unaudited [4]. Counsel's chief executive said in the release that physicians stay in the loop for clinical decisions [4].
Abu Dhabi and India: AI as a documentation layer
Abu Dhabi's Department of Health, working with M42's Abu Dhabi Health Data Services, announced on 10 November that an AI Physician Assistant powered by M42's Ossi platform is now integrated into Malaffi, the emirate's health information exchange [5]. According to the announcement, Malaffi holds health information on more than 14 million patients and over four billion clinical records, Ossi is hosted on Microsoft Azure's cloud in the UAE, and clinical assessment and decisions remain the physician's responsibility [5]. The implementation "will be evaluated", with findings and user feedback informing later phases [5]. No accuracy data has been published.
India's National Health Authority selected Bengaluru-based EkaCare through an expression-of-interest process to deploy an ambient voice scribe in public facilities under the Ayushman Bharat Digital Mission, according to EkaCare's announcement as published by the Economic Times [6]. It is built on EkaCare's Parrotlet-A speech model, which the company describes as open-source, supports more than 15 Indian languages, writes notes in the FHIR format and requires a verified doctor to review and approve every note before it is saved [6]. This is reported from company-supplied material; we found no NHA statement.
China: the commercial pull
Reuters reported on 11 November that apps from Alibaba Health, JD Health and others are drawing doctors, with Alibaba Health saying 93% of the hundreds of doctors it surveyed now use AI tools, up from about 70% a year earlier [7]. Alibaba Health is considering letting drugmakers' promoted evidence appear next to AI answers on its Hydrion app, but has not started collaborating with drugmakers; Roche said it is exploring third-party tools for marketing to doctors [7]. Reuters links the interest to Beijing's anti-graft campaign, which made traditional visits harder [7].
United Kingdom: oversight after approval
On 6 October the UK government accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, promising regulation balanced between pre-market and post-market stages [9]. Raconteur reports the response does not settle who is liable if medical AI fails, and that NHS Resolution says claims are more likely against the care provider than the developer [8]. The Medicines and Healthcare products Regulatory Agency plans draft guidance by December 2026 on predetermined change control plans, which would set limits on software updates [8]. A Medical Protection official warned clinicians could become a "liability sink" [8].
How the regions compare
| Region | What launched | Status | Human sign-off stated | Published results |
|---|---|---|---|---|
| US | Gemini for healthcare | Preview | Yes, "appropriate human oversight" | None found |
| US | Oura to buy Counsel Health | Agreed, not closed | Physicians in the loop | None found |
| Abu Dhabi | AI Physician Assistant in Malaffi | Announced | Physicians decide | Evaluation planned |
| India | EkaCare voice scribe | Selected | Every note approved | None found |
| China | Doctor AI apps | Market forming | Not covered | Alibaba survey |
| UK | Post-approval monitoring | Draft guidance due | Liability unresolved | Not applicable |
Our take
Our analysis: the products are converging on the same safe-looking job, summarising records and writing notes while a clinician signs off. That is sensible, but the evidence is thin. We found no independent accuracy results for any of the tools in the US, Abu Dhabi or India, and the UK discussion shows why that matters: performance can drift between hospitals and after updates. The China story is the one to watch for incentives, because paid promotion beside AI answers could blur medical evidence and advertising. For buyers, the practical question is not whether the tool has a human in the loop, but who measures it after launch. Strengths: less paperwork, multilingual notes. Weaknesses: unproven accuracy, unclear liability, vendor lock-in risk with proprietary data connectors.
What to watch next
- Abu Dhabi's evaluation findings and any accuracy data from Gemini for healthcare partners.
- Whether Oura's acquisition closes by year end.
- The MHRA draft guidance due by December 2026.
- Any disclosure rules for sponsored content in Chinese medical AI apps.
FAQ
What is Gemini for healthcare? A Google Cloud product for health providers and plans that runs records synthesis and prior-authorisation workflows; it is in preview [1][2].
How much is Oura paying for Counsel Health? $625 million in cash, subject to purchase price adjustments, with closing expected before the end of the calendar year [4].
Does the Abu Dhabi assistant make clinical decisions? No. The announcement says clinical assessment and decisions remain the responsibility of the physician [5].
This article is analysis, not medical, legal or investment advice.
Sources
- Introducing Gemini for healthcare, Google Cloud Blog, 10 November 2026. Primary.
- Google Cloud launches Gemini for healthcare, Google, 10 November 2026. Primary.
- InterSystems Joins Google Cloud as Launch Partner for Gemini for Healthcare, Google Cloud Press Corner, 10 November 2026. Primary.
- Oura to Acquire Counsel Health, Advancing Vision for More Connected, Personalized Healthcare, Counsel Health newsroom (Oura and Counsel Health release), 10 November 2026. Primary.
- Abu Dhabi Integrates AI Physician Assistant into Malaffi, Malaffi, 10 November 2026. Primary.
- EkaCare selected as tech partner for National Health Authority's ambient AI-enabled voice scribe solution, Economic Times (EkaCare announcement), 11 November 2026.
- Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing, Reuters, 11 November 2026.
- The UK rethinks healthcare AI regulation, Raconteur, 9 November 2026.
- Government response to the National Commission's recommendations on the regulation of AI in healthcare, UK Government, 6 October 2026. Primary.
AI Worldwire is independent and has no commercial relationship with the companies covered, unless stated. Research and drafting are assisted by AI; every article is reviewed and approved by a human editor before publication. Subscribe to the AI Worldwire newsletter.